Nutrition 21 Ends Patent Infringement Lawsuit with SuperNutritionNutrition 21 Ends Patent Infringement Lawsuit with SuperNutrition
JDS Therapeutics LLC and its subsidiary, Nutrition 21 LLC announced today that they have entered into a confidential settlement and license agreement with SuperNutrition Life-Extension Research, Inc.
July 23, 2014
PURCHASE, New York—JDS Therapeutics LLC and its subsidiary, Nutrition 21 LLC announced today that they have entered into a confidential settlement and license agreement with SuperNutrition Life-Extension Research Inc.
The settlement ends a patent and trademark infringement lawsuit brought by Nutrition 21 against SuperNutrition in the Southern District of New York related to SuperNutrition’s use of Nutrition 21’s Chromax trademark and chromium polynicotinate in their branded multivitamin products. The terms of the settlement are confidential, however, in conjunction with the settlement, SuperNutrition has agreed to license Nutrition 21’s various chromium polynicotinate patents and its Chromax and Niachrome trademarks and utilize Nutrition 21’s Niachrome brand of chromium polynicotinate for its applicable formulation needs.
“We are delighted that we were able to reach a customer-driven solution with respect to our dispute with SuperNutrition," said Gregg Bresner, chief financial officer, Nutrition 21. “SuperNutrition has been an innovative company in the market for decades, and we are excited to provide Niachrome to SuperNutrition for use in its branded family of multivitamin products. We believe this reaffirms the strength of Nutrition 21’s trademarks, and its patent portfolio which covers compositions and uses of a number of our products, including our Niachrome chromium polynicotinate."
You May Also Like
Beyond vaginal microbiota: Emotional well-being, gut health support – white paperNov 22, 2023
Custom 'biotic' solutions for digestive health – infographicDec 07, 2023
EPA and DHA help distance runners avoid muscle damage in sports nutrition studyDec 07, 2023
Generation Alpha emerges as a sophisticated and desirable target marketDec 07, 2023